444

AMCAD BIOMED CORPORATION

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪1.48 B‬TWD
−0.85TWD
‪−45.31 M‬TWD
‪65.26 M‬TWD
‪47.99 M‬
Beta (1Y)
0.17

About AMCAD BIOMED CORPORATION

CEO
Yi Li Lee
Headquarters
Taipei
Founded
2008
ISIN
TW0004188008
FIGI
BBG005Q5BB47
AmCad BioMed Corp. engages in the manufacture and sale of medical diagnostic software device. Its products include AmCAD-UT Detection and AmCAD-UT Diagnosis. The company was founded on December 26, 2008 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 4188 is 27.15 TWD — it has increased by 0.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange AMCAD BIOMED CORPORATION stocks are traded under the ticker 4188.
AMCAD BIOMED CORPORATION is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
4188 stock is 3.73% volatile and has beta coefficient of 0.17. Check out the list of the most volatile stocks — is AMCAD BIOMED CORPORATION there?
Yes, you can track AMCAD BIOMED CORPORATION financials in yearly and quarterly reports right on TradingView.
4188 stock has risen by 6.47% compared to the previous week, the month change is a 6.70% fall, over the last year AMCAD BIOMED CORPORATION has showed a 72.38% increase.
4188 net income for the last quarter is ‪−10.90 M‬ TWD, while the quarter before that showed ‪−10.81 M‬ TWD of net income which accounts for −0.81% change. Track more AMCAD BIOMED CORPORATION financial stats to get the full picture.
Today AMCAD BIOMED CORPORATION has the market capitalization of ‪1.44 B‬, it has decreased by 2.95% over the last week.
No, 4188 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4188 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMCAD BIOMED CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
4188 reached its all-time high on Dec 26, 2013 with the price of 71.80 TWD, and its all-time low was 11.25 TWD and was reached on Mar 19, 2020.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AMCAD BIOMED CORPORATION technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AMCAD BIOMED CORPORATION stock shows the buy signal. See more of AMCAD BIOMED CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AMCAD BIOMED CORPORATION EBITDA is ‪−36.52 M‬ TWD, and current EBITDA margin is −55.96%. See more stats in AMCAD BIOMED CORPORATION financial statements.